← Leaderboards
Daisy Deleon
Loma Linda University
$1,330,368
Attributed
$1,330,368
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,330,368 · 1
By mechanism
P20$1,330,368 · 1
Top collaborators
No co-investigators on record.
Most similar at Loma Linda University
Same institution · by research overlap
- Daisy D. De Leon$1,017,402
- Marino De Leon$16,562,821
- Teleka Cassandra Calderon$94,704
Others in their field
Top investigators on “Accounting”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$185,928,938
- Zeljko Ivezic · University Of Washington$142,654,512
- Victor Krabbendam · Association Of Universities For Research In Astronomy, Inc.$142,654,512
- Steven M Kahn · Association Of Universities For Research In Astronomy, Inc.$142,654,512
Research focus
AccountingEstrogensAffectAmericanEpidemiologic StudiesAfricanAfrican AmericanBaseBinding (Molecular Function)BiologicalAnimal ModelCancer Cell GrowthCancer PatientAnimalsCathepsinsCaucasiansCaucasoid RaceCell ProliferationCellsCharacteristicsDietary FatsDisease ProgressionBreast Cancer CellEthnic Group
Grant awards (5)
Cathepsin D, IGF-II and EFABP promotes breast cancer progression in African Amer.$272,430
P20 · FY2009 · MD · contact PI
Cathepsin D, IGF-II and EFABP promotes breast cancer progression in African Amer.$271,941
P20 · FY2008 · MD · contact PI
Cathepsin D, IGF-II and EFABP promotes breast cancer progression in African Amer.$299,997
P20 · FY2007 · MD · contact PI
Cathepsin D, IGF-II and EFABP promotes breast cancer progression in African Amer.$243,000
P20 · FY2006 · MD · contact PI
Cathepsin D, IGF-II and EFABP promotes breast cancer progression in African Amer.$243,000
P20 · FY2005 · MD